Powered by RND
PodcastsEducationMicrobe Mail

Microbe Mail

Vindana Chibabhai
Microbe Mail
Latest episode

Available Episodes

5 of 75
  • Outbreak response
    In this episode, we dive into the world of outbreak response with two incredible guests from South Africa’s National Institute for Communicable Diseases. Drawing from their wealth of experience on the front lines of investigating and containing infections of public health concern, they share insights into what it really takes to respond swiftly, strategically, and effectively when outbreaks strike.About our Guests:Dr Vuyiswa Kumalo is a medical officer in the Outbreak Response Unit of the National Institute for Communicable Diseases. She has over a decade’s experience as a clinician, currently pursuing a specialist physician fellowship in Public Health Medicine. She has extensive experience and expertise in clinical research and community health technical skills, and knowledge. Dr. Saffiya Umar is a medical Officer at the NICD’s Outbreak Response Unit of the National Institute for Communicable Diseases. She graduated from UKZN and has since garnered a wealth of knowledge in community health. She has a special interest in tropical medicine, communicable diseases and public health. WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: [email protected]
    --------  
    30:16
  • Managing menacing Malaria
    In this episode, we take a comprehensive look at malaria management—from selecting the appropriate treatment for each Plasmodium species, to recognising and treating complications, and exploring prophylaxis. Whether you're refreshing your knowledge or managing cases on the front line, this episode is packed with practical insights from our expert, who is back for a 2nd feature episode, Professor Lucille Blumberg.About our Guest: Professor Lucille Blumberg, MB BCH MMed (Clin Micro) ID (SA) FFTM (RCP Glasgow, travel medicine) DTM&H DOH DCH D.Sc. (Med) honoris. She is a highly respected infectious diseases specialist and medical microbiologist, hailing from Johannesburg, who sits on many national and international expert groups. Her contribution to keeping the public safe from infectious disease has been hailed as the epitome of sustainable, groundbreaking research. She has honorary appointments at the National Institute for Communicable Diseases (NICD), the Universities of Stellenbosch (Medical Microbiology) and University of Pretoria (Faculty of Veterinary Sciences), South Africa. Her focus is on outbreak prevention and response, emerging diseases, travel-related infections, the viral haemorrhagic fevers, malaria and zoonosis, especially rabies. She is the current chair of the Strategic Advisory Group for Infectious Hazards for the WHO Emergencies Programme and a member of the scientific advisory group for the WHO Neglected Tropical Diseases programme. She is a longstanding member of the National Rabies Advisory Group in South Africa and is the former chair of the South African Malaria Elimination Committee (SAMEC). Prof Blumberg has been involved in the prevention, detection and response to several communicable disease outbreaks, including cholera, typhoid, rabies, the Viral Haemorrhagic Fevers (Lujo, Rift Valley fever, Ebola), influenza (pandemic A H1N1, and Avian Influenza A H5N2) and diphtheria. Her special interests are malaria, rabies, other zoonoses, East African Trypanosomiasis, travel and tropical medicine and border health issues. She has worked with Right to Care as a Technical Scientific Advisor since 2021. She has recently been appointed to the editorial board of the Southern African Journal of Infectious Diseases. Other editorial positions include being African Advisor for the International Journal of Travel Medicine since 2018, and one of three editors for the International Journal of Infectious Diseases since 2017. During the COVID-19 pandemic, she established DATCOV, a national surveillance system for patients with COVID-19 who were hospitalised. WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: [email protected]
    --------  
    35:59
  • From Bite to Brain: Revealing Rabies
    This episode pits man’s best friend against one of man’s deadliest foes—rabies doesn’t play fetch nor does it leave many unscathed. Ruan speaks to one health champion and ID friend to many, Professor Lucille Blumberg, and they talk about the virus that turns loyal companions into lethal threats. How to diagnose it, how it's managed and most importantly how to prevent it.About our Guest: Professor Lucille Blumberg, MB BCH MMed (Clin Micro) ID (SA) FFTM (RCP Glasgow, travel medicine) DTM&H DOH DCH D.Sc. (Med) honoris. She is a highly respected infectious diseases specialist and medical microbiologist, hailing from Johannesburg, who sits on many national and international expert groups. Her contribution to keeping the public safe from infectious disease has been hailed as the epitome of sustainable, groundbreaking research. She has honorary appointments at the National Institute for Communicable Diseases (NICD), the Universities of Stellenbosch (Medical Microbiology) and University of Pretoria (Faculty of Veterinary Sciences), South Africa. Her focus is on outbreak prevention and response, emerging diseases, travel-related infections, the viral haemorrhagic fevers, malaria and zoonosis, especially rabies. She is the current chair of the Strategic Advisory Group for Infectious Hazards for the WHO Emergencies Programme and a member of the scientific advisory group for the WHO Neglected Tropical Diseases programme. She is a longstanding member of the National Rabies Advisory Group in South Africa and is the former chair of the South African Malaria Elimination Committee (SAMEC). Prof Blumberg has been involved in the prevention, detection and response to several communicable disease outbreaks, including cholera, typhoid, rabies, the Viral Haemorrhagic Fevers (Lujo, Rift Valley fever, Ebola), influenza (pandemic A H1N1, and Avian Influenza A H5N2) and diphtheria. Her special interests are malaria, rabies, other zoonoses, East African Trypanosomiasis, travel and tropical medicine and border health issues. She has worked with Right to Care as a Technical Scientific Advisor since 2021. She has recently been appointed to the editorial board of the Southern African Journal of Infectious Diseases. Other editorial positions include being African Advisor for the International Journal of Travel Medicine since 2018, and one of three editors for the International Journal of Infectious Diseases since 2017. During the COVID-19 pandemic, she established DATCOV, a national surveillance system for patients with COVID-19 who were hospitalised. WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: [email protected]
    --------  
    52:02
  • Malaria vaccines: The French episode
    Dans un monde où une piqûre de moustique peut encore être mortelle, il est réconfortant de savoir que notre mentalité s'oriente désormais vers la prévention et l'élimination. Dans cet épisode, Miriam s'entretient avec le Dr Abdouramane Camara, un lauréat de la Bourse d'accélération de carrière en Afrique et pionnier en immunologie, au sujet des vaccins antipaludiques.À propos de notre invité: Le Dr Abdouramane Camara est chercheur postdoctoral au West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), à l'Université du Ghana. Après plus de dix ans passés dans plusieurs institutions européennes, il a su forger une solide expertise, le Dr Camara est revenu en Afrique pour contribuer à son avancement scientifique en développant un nouveau test clinique permettant d'évaluer l'efficacité des vaccins à un stade précoce et de prédire la protection à long terme.Ses travaux de recherche visent à élucider les mécanismes impliqués dans la génération des plasmocytes à longue durée de vie et des cellules productrices d’anticorps, ainsi qu’à explorer leur capacité à prédire précocement l’efficacité d’une vaccination. Il s'intéresse particulièrement au paludisme, une maladie endémique dans de nombreux pays africains, et à l'efficacité des nouveaux vaccins antipaludiques. Au-delà du paludisme, il étudie également les vaccins procurant une immunité à long terme, voire à vie, afin de contribuer à l'amélioration de la conception et des stratégies de mise en Å“uvre des vaccins.Malaria life cycle: Reproduced from PATH's Malaria Vaccines website at www.malariavaccine.org, 2024Global Malaria programmeNOUS AIMERIONS VOTRE AVIS SUR CET ÉPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: [email protected]
    --------  
    25:06
  • Malaria vaccines: The English episode
    In a world where a mosquito bite can still be deadly, it is comforting to know that our mindset has shifted towards prevention and elimination. In this episode, Ruan speaks to a fellow recipient of the African Career Acceleration Fellowship, Dr Abdouramane Camara who is a pioneer in immunology, about malarial vaccines.About our Guest: Dr Abdouramane Camara is a postdoc research fellow at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana. After spending over a decade in various institutions across Europe, gathering immense expertise, Dr Camara has returned to Africa to contribute to its scientific advancement by developing a new clinical test to evaluate the efficacy of vaccines at an early stage and predict long-term protection.His research focuses on understanding the mechanisms underlying the generation of long-lived plasma cells, antibody-secreting cells and their potential to be early predictors of vaccination success. He is particularly interested in malaria, a disease endemic to many African countries, and the efficacy of newly introduced malaria vaccines. Beyond malaria, he is also investigating vaccines that provide long-term or lifelong immunity, aiming to contribute to improved vaccine design and implementation strategies.Malaria life cycle: Reproduced from PATH's Malaria Vaccines website at www.malariavaccine.org, 2024Global Malaria programmeWE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: [email protected]
    --------  
    21:54

More Education podcasts

About Microbe Mail

Are you looking for a medical podcast covering every day issues in diagnostic tests, antimicrobial therapy and management of infections that is relevant to a low or middle income setting? A show that simplifies complex concepts in an easy to follow conversational format? You've come to the right place. This is Microbe Mail - a medical podcast for the busy practitioner or student covering topics in microbiology, infectious diseases and infection control. Sign up to our newsletter to receive updates on new episode releases at: https://microbemail.captivate.fm/ Contact us at [email protected]
Podcast website

Listen to Microbe Mail, The Mel Robbins Podcast and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v7.21.1 | © 2007-2025 radio.de GmbH
Generated: 7/15/2025 - 11:29:48 PM